http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2475535-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ef9b63dffa476acb1256d48771f6a30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74a8fe4a355db9424dc415769850ff7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a0ca31ef914cd10dc4dd0343d494c4e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
| filingDate | 2011-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_296596476d5623dc1f159fcb9ac1bbff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b79868651e21dfc1e70a6e77e620a45 |
| publicationDate | 2013-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2475535-C1 |
| titleOfInvention | Method to produce probiotic preparation lacto-amylovorin |
| abstract | FIELD: biotechnologies. n SUBSTANCE: probiotic lacto-amylovorin is produced by means of depth growth of the strain Lactobacillus amylovorus RNCIM B-6253 on the liquid nutrient medium, which contains the following: corn extract - 10 ± 0.01 ml, lactose - 20 ± 0.005 g, chemically deposited chalk - 0.5 ± 0.01 g, triple-substituted citric-acid sodium - 7.5 ± 0.05 g, 3-water acetous sodium - 2 ± 0.01 g, iron sulfate - 0.1± 0.001 g, 5-water manganese sulfate - 0.16 ± 0.002 g, hydrolysate of dry nonfat milk - up to l. Subsequent extraction of the target product in liquid condition or in the form of a dry powder is carried out with preliminary addition of a stabiliser to a cultural liquid or to a protective medium used when producing the probiotic in the form of the dry powder. The stabiliser is selected from: sodium metabisulfite, sodium hydrosulfite and ascorbic acid. n EFFECT: invention provides for stable production of a probiotic with high values of a titre of antimicrobial bodies not only in a cultural liquid, but also after its treatment required for production of different pharmaceutical forms of a preparation. n 3 cl, 2 tbl, 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2724585-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2767400-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2675934-C2 |
| priorityDate | 2011-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.